Badrilla Ltd,成立于2003年,是一家的生命科學公司,為主要制藥,生物技術和學術機構中的分子心血管研究人員提供高質量的產品。Badrilla協助研究人員將有機化學和蛋白質化學方面的專業知識與蛋白質的翻譯后修飾知識相結合,以協調心臟的興奮與收縮耦合,心律失常和肥大以及導致心力衰竭的適應不良反應,從而在過去的十年中,Badrilla產品幫助鞏固了心臟生物化學領域的重要發現,并且該公司從科學家那里獲得了大量已發表的數據。
上海起發Badrilla2021年價格表
貨號 | 品名 | 規格 | 價格 | 品牌 |
K010-310 | CAPTUREomeTM S-Palmitoylated Protein Mini Kit | Kit | 3552.15 | Badrilla2021 |
K010-311 | CAPTUREomeTM S-Palmitoylated Protein Kit | Kit | 8907.15 | Badrilla2021 |
K010-312 | SiteCounter S-Palmitoylated Protein kit | Kit | 8907.15 | Badrilla2021 |
K010-313 | SiteCounter S-Palmitoylated Protein Mini kit | Kit | 3552.15 | Badrilla2021 |
K010-410 | Click S-Palmitoylation Detection-775 Kit | Kit | 8015.364 | Badrilla2021 |
A010-701 | ML348 (inhibitor of acyl palmitoyl thio-esterase 1 (APT1)) | 1 mg | 1071 | Badrilla2021 |
A010-702 | ML349 (inhibitor of acyl palmitoyl thio-esterase 2 (APT2)) | 1 mg | 1071 | Badrilla2021 |
A010-601 | AccuMarQ Pre-stained Molecular Weight Markers (10-240kDa) | Kit | 1963.5 | Badrilla2021 |
A010-10AP | Phospholamban (PLN,PLB) (pSer10) pAb affinity purified | 50ug | 5801.25 | Badrilla2021 |
A010-12 | Phospholamban (PLN, PLB) (pSer16) pAb serum | 25µl | 5801.25 | Badrilla2021 |
A010-12AP | Phospholamban (PLN, PLB) (pSer16) pAb affinity purified | 50µl | 9728.25 | Badrilla2021 |
A010-13 | Phospholamban (PLN, PLB) (pThr17) pAb serum | 25µl | 5801.25 | Badrilla2021 |
A010-13AP | Phospholamban (PLN, PLB) (pThr17) pAb affinity purified | 100µl | 9728.25 | Badrilla2021 |
A010-14 | Phospholamban (PLN, PLB) mAb (clone A1) | 25µg | 5801.25 | Badrilla2021 |
A010-110 | Phospholemman (PLM) (pSer63) pAb | 100ml | 5801.25 | Badrilla2021 |
A010-111 | Phospholemman (PLM) (pSer68) pAb | 100ml | 5801.25 | Badrilla2021 |
A010-112 | Phospholemman (PLM) (pThr69) pAb | 100ml | 5801.25 | Badrilla2021 |
A010-113 | Phospholemman (PLM) (Ser68/pThr69) pAb | 100ml | 5801.25 | Badrilla2021 |
A010-20 | SERCA2a pAb serum | 20µl | 5801.25 | Badrilla2021 |
A010-21AP | SERCA1/2 mAb (clone Y/1F4) | 50µl | 5801.25 | Badrilla2021 |
A010-22AP | SERCA1 mAb (clone B/4H3) | 50µl | 5801.25 | Badrilla2021 |
A010-23L | SERCA2a pAb serum | 100µl | 6515.25 | Badrilla2021 |
A010-23S | SERCA2a pAb serum | 20µl | 2320.5 | Badrilla2021 |
A010-24L | SERCA2b pAb serum | 100µl | 6515.25 | Badrilla2021 |
A010-24S | SERCA2b pAb serum | 20µl | 2320.5 | Badrilla2021 |
A010-25AP | SERCA2 (pSer38) pAb affinity purified | 50µl | 5801.25 | Badrilla2021 |
A010-30 | Ryanodine receptor 2 (RYR2) (pSer2808) pAb serum | 50µl | 10692.15 | Badrilla2021 |
A010-30AP | Ryanodine receptor 2 (RYR2) (pSer2808) pAb affinity purified | 100µl | 11691.75 | Badrilla2021 |
A010-31 | Ryanodine receptor 2 (RYR2) (pSer2814) pAb serum | 50µl | 10692.15 | Badrilla2021 |
A010-31AP | Ryanodine receptor 2 (RYR2) (pSer2814) pAb affinity purified | 100µl | 11691.75 | Badrilla2021 |
A010-32 | Ryanodine receptor 2 (RYR2) (pSer2030) pAb serum | 50µl | 10692.15 | Badrilla2021 |
A010-35AP | Ryanodine receptor 2 (RYR2) (dephoSer2808) pAb affinity purified | 100µl | 11691.75 | Badrilla2021 |
A010-514 | DPc10 Peptide | 200mg | 2829.0465 | Badrilla2021 |
A010-515 | DPc10 Inactive Peptide | 200mg | 2829.0465 | Badrilla2021 |
A010-516 | Fluorescein DPc10 Peptide | 200mg | 2829.0465 | Badrilla2021 |
A010-517 | Fluorescein DPc10 Inactive Peptide | 200mg | 2829.0465 | Badrilla2021 |
A010-519 | DPc10 Cell Permeable Peptide | 1mg | 6024.375 | Badrilla2021 |
A010-520 | Fluorescein DPc10 Cell permeable peptide | 0.1mg | 2856 | Badrilla2021 |
A010-50 | CaMKII (pThr286 or 287) pAb serum | 20µl | 5801.25 | Badrilla2021 |
A010-50AP | CaMKII (pThr286 or 287) pAb affinity purified | 50µl | 5801.25 | Badrilla2021 |
A010-56AP | CaMKII delta isoforms (2/3/4/9/11/11a) pAb affinity purified | 100ug (50µl) | 5801.25 | Badrilla2021 |
A010-2E11 | Nitrotyrosine mAb (clone 2E11) | 50µg | 5801.25 | Badrilla2021 |
A010-6B2 | Nitrotyrosine mAb (Clone 6B2) | 20µl | 5801.25 | Badrilla2021 |
A010-513 | Nitrotyrosine Western blot starter pack | Kit | 7497 | Badrilla2021 |
A010-mCherry-5 | Red fluorescent protein (mCherry) pAb epitope purified | 5ug | 1249.5 | Badrilla2021 |
A010-mCherry-50 | Red fluorescent protein (mCherry) pAb epitope purified | 50ug | 5801.25 | Badrilla2021 |
A010-mEOS | mEOS2 pAb | 50ug | 5801.25 | Badrilla2021 |
A010-myc-5 | c-myc mAb (clone 9E10.2) | 5mg | 1249.5 | Badrilla2021 |
A010-myc-50 | c-myc mAb (clone 9E10.2) | 200µg | 5801.25 | Badrilla2021 |
A010-myc-BULK | c-myc mAb (clone 9E10.2) | 1mg | 9371.25 | Badrilla2021 |
A010-pGFP-5 | Green fluorescent protein (GFP, EGFP) pAb epitope purified | 5ug | 1249.5 | Badrilla2021 |
A010-pGFP-50 | Green fluorescent protein (GFP, EGFP) pAb epitope purified | 50ug | 5801.25 | Badrilla2021 |
A-b2AR-100 | β-2 Adrenergic receptor (β-2AR) pAb | 100µl | 5622.75 | Badrilla2021 |
A-b2AR-25 | β-2 Adrenergic receptor (β-2AR) pAb | 25µl | 1874.25 | Badrilla2021 |
A010-40AP | Erk 1/2 (pThr188) pAb affinity purified | 50µl | 5801.25 | Badrilla2021 |
A010-70 | L-type Ca2+ channel (Cav1.2) (pSer1928) pAb | 50µl | 10692.15 | Badrilla2021 |
A010-80 | Calcineurin (pSer197) pAb serum | 100µl | 5801.25 | Badrilla2021 |
電話
QQ咨詢
4006551678